NO | Önümler | Kas | Esasy hil görkezijisi | |||
Arassalylyk | Maks. çökgünlik | Jemi çözüji galyndy | Çyglylyk | |||
1 | FMOK-ALA-ALA-ALA-ALA-oa | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | FMOC-D-Ala-D-Ala-ALA-Aý | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | Fmoc-β-ala-d-aa-oa-oa | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | FMCC-AG (PBF) -arg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | Fmoc-β-ala-ara-ara (pbf) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | FMCC-D-AG | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | Fmoc-β-ala-d-sm (pbf) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | Fmoc-goomoarg (pbf) -oamarg (pbf) -o -Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | Fmoc-β-ala-gooarg (pbf) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | FMOC-Asn (TRT) -ASN (TRT) --HOh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | Fmoc-a - ala-asn (TRT) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | Fmoc-asp (oTBu) -asp (otbu) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | Fmoc-β-ala-asp (otbu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | Fmoc-tys (TRT) (TRT) (TRT) (TRT )-S | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | Fmoc-aa-cys (TRT) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | Fmoc-Cys (ACM) -atlar (ACM) -o -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | Fmoc-β-ala-cys (acm) -o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | FMOC-Gln (TRT) -GLn (TRT) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | Fmoc-aa-ala-gln (TRT) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | FMCC-Glu (OTBU) -gllu (OTBU) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | FMC-Aβ-ALA-Glu (OTBU) -ok.h2o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | Fmoc-β-ala-gly-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | FMOC-His (TRT) -His (TRT) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | FMOK-ALA-ALA-On (TRT) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | FMOC-ILE-ILE-OH-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | FMOK-Ala-ALA-ILE-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | FMOK-LEU-LEU-OH-ч | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | Fmoc-β-ala-leu-lu-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | FMCC-D-LEU-D-LEU-ч | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | FMC-Aβ-ALA-D-D-leu-LEU-ч | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | FMOC-ly syzlary (BOC) -lys (BOC) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | Fmoc-β-Ala-Liz (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | FMOK-len lens (Betsoc) -lys (Betss) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | Fmoc-β-ala-lss (Betsoc) -Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | FMOC-MET-MEAL-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | Fmoc-β-ala-metal | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | Fmoc-orn (boc) -orn (boc) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | Fmoc-β-ala-orn (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | Fmoc-she-she-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | Fmoc-β-ala-she-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | Fmoc-d-ph-d-phe-ph-sh- | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | Fmoc-β-ala-d-phee | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | Fmok--prof--pro-wh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | Fmoc-β-ala-pro-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | Fmoc-Seres (tbu) -ser (tbu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | Fmoc-β-ala-ser (tbu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | Fmoc-ser (TRT) -z (TRT) - WASP (TRT) --H.h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | Fmoc-β-ala-ser (TRT) - Mor | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | Fmoc-thr (tbu) -at (tbu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | Fmoc-aa-thr (tbu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | FMOC-TRP (Boc) -trp (BOC) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | FMC-Aβ-ALA-TRP (BOC) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | FMOC-D-TRP (BOC) -D-TRP (Boc) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | Fmoc-β-ala-d-trp (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | Fmoc-öňe (tbu) -tyr (tbu) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | Fmoc-β-ala-Trer (tbu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | FMCC-D-TY (ET) -D -D-TR TRR (Et) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | FMOK-ALA-D-D-D-TR TRA (ET) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | FMOK-TERR (MEN) -tyR (men) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | FMC-Aβ-ALA-TRR (MEN) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | Fmoc-Wal-Wal-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | FMC-Aβ-ALA-Wal-WA-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | FMOK-D-D-D-D-D-D-D-DT-Aý | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | Fmoc-β-ala-d-d-d-d-d-dat | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | Fmoc-β-ala-Daba-Daba | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | FMOC- (3- (2-Naphththil) -d--D-ALA-ALA-ALA) 2-Aý | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | Fmoc-β-ala-3- (2-naphththil) -d--d-Ala-oa-oa | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | FMOC- (3- (3 pýridhodyil) -d--D-ALA-ALA-ALA) 2 -H | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | Fmoc-β-ala-3- (3 pýridinil) -d-bil-ala-oa-oa | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | FMOC- (4-Çlo-D-PH-D-PH-STHE) 2 -H | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | Fmoc-β-ala-4-hloro-d-d-s | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | Fmok- (d-4af) 2 -H | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | Fmoc-β-ala-d-4af (tbucmm) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | FMCC-APH (l-hor) - (l-hor) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | Fmoc-β-ala-aph (l-hor) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | FmoC-ly ly ly lyS (IP, Boc) -lys (IP, Boc) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | Fmoc-β-ala-ls (IP, Boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | Fmoc-β-ala-Aeea-oea-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | FMOC-AIB-AIB-AIB-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | Fmoc-β-ala-aib-aib-aih | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | Flamo-ar-oh | 91000-69-6-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | H-AG (PBF) -oh | 2001115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | FMOC-D-SAR-AH - OH | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | HD-SARK (PBF) -oh | 200119-81-81-81-81-81-81-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | FMOC-goomoarg-oh.hcl | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | H-gomoarg (pbf) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | Fmoc-d-goomoarg-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | HD-gomoarg (pbf) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | FMOC-ASN-OH | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | H-Asn (TRT) - | 132388-58-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | Fmok-asp-oh | 119062-05-4-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | H-asp (OTBU) - | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | Fmok-Cys-OH | 135248-89-8-4-4-8-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | H-cys (TRT) - | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | H-Cys (ACM) -ok.hcl | 28798-28-9-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | Fmoc-gln-oh | 71989-2-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | H-gln (TRT) - | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | Fmoc-Glu-oh | 12133-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | H-Glu (OTBU) -ok.h2o | 2419-56-9-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
100 | Fmoc-he-oh | 116611-64-4-4-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
101 | H--da (TRT) - | 35146-32-8-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
102 | Boc-the-oh | 17791-52-552-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
103 | Fmok-lys-ah | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
104 | H-lis (Boc) -oh | 2418-95-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
105 | H-Lys (BEKT) -ok | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
106 | FMOK-OH.HCL | 201046-57-3-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
107 | H-orn (boc) -o | 13650-49-2-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
108 | Fmoc-Seres-nji ser | 73724-45-5-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
109 | H-Seres (TBU) - | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
110 | H-serleri (TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
111 | Fmoc-thr-oh.h2o | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
112 | H-Thr (TBU) - | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
113 | FMOC-TRP-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
114 | H-TRP (BOC) - | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
115 | Fmoc-d-trp-oh | 86123-11-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
116 | HD-TRP (BOC) - | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
117 | Fmoc-Ter-oh | 92954-90-0-00-00-0-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
118 | H-Taýr (TBU) - | 18822-59-8-8-8-8-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
119 | Fmoc-d-tak-oh | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
120 | HD-TYR (ET) - - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
121 | H-Taýr (MEN) -ok.hcl | 67423-43-33 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
122 | Fmoc-d-4af (cbm) - | 324017-22-3-3-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
123 | HD-4OAP (tbucbm) -ok | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
124 | Fmok-ly syzlary (IPR) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
125 | H-lis (IP, Boc) -o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Öwezini dolmak
Gent -OLEX iň oňat hilli önümler, müşderi üçin ýeterlik "mysallaryň ýeterlik bolmagy üçin zerur bolan bolsa, zerur möhletli ahyrzulandyrsa zerur möhletli öküz öndürijisi, sebäbi önümiň hili ýeterlik däl bolsa, öwezini dolmak üçin zerur bolan bolsa, öwezini dolmak prosedurasyna zerur derňewden we baha bermekdir.
Önümçilik
Derman önümleriniň mümkinçilikleri, mondarlyk derejesine ýetdi, 100taça derejä ýetip, mümkinçiliklere ýetmek üçin mümkinçiliklere hyzmat etmek üçin mümkinçiliklere eýedir.
Gözleg we ösüş
Maksatlar goýlanda, dürli täze önümleri birleşikde, topardaky her bir agza KPI jogapkärçiligi we höwes bilen syýasaty bilen amala aşyraryş meýilnamasy bar.